BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15269606)

  • 1. Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia.
    Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Fujimaki K; Taguchi J; Ishigatsubo Y
    Anticancer Drugs; 2004 Aug; 15(7):729-31. PubMed ID: 15269606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission.
    Birnie GD; MacKenzie ED; Goyns MH; Pollock A
    Leukemia; 1990 Jun; 4(6):452-4. PubMed ID: 2359346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia.
    Radojkovic M; Ristic S; Colovic M; Todoric B; Krtolica K
    Med Oncol; 2001; 18(3):227-9. PubMed ID: 11917947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination therapy of chronic myelogenous leukemia with busulfan and bestatin].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):571-8. PubMed ID: 2012399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive cytogenetic studies of clonality following interferon-alpha therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic.
    Takeshita A; Shinjo K; Yamashita M; Fujisawa S; Naito K; Ohnishi K; Takahashi K; Matsui H; Ohno R
    Leukemia; 1999 Nov; 13(11):1749-53. PubMed ID: 10557048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone.
    Mandigers CM; Mensink EJ; Geurts van Kessel A; van der Plas DC; Haanen C; Hagemeÿer A; de Witte T
    Ann Hematol; 1996 Jun; 72(6):371-3. PubMed ID: 8767106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
    Itoh T; Tamura S; Takemoto Y; Kakishita E
    Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bestatin treatment of myelodysplastic syndromes and chronic myelogenous leukemia.
    Usuka Y; Saito Y
    Biomed Pharmacother; 1991; 45(2-3):87-93. PubMed ID: 1912373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
    Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].
    Nagafuji K; Iwakiri R; Miyamoto T; Okamura H; Yokota E; Matsumoto I
    Rinsho Ketsueki; 1992 Sep; 33(9):1226-30. PubMed ID: 1433945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.
    Santucci MA; Zaccaria A; Testoni N; Russo D; Zuffa E; Baccarani M; Tura S
    Haematologica; 1991; 76(5):357-62. PubMed ID: 1806437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of simultaneous bone marrow cytogenetic and peripheral blood molecular responses in chronic myeloid leukemia].
    Lai Y; Qin Y; Huang X; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):104-8. PubMed ID: 24606648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
    Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
    Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bestatin therapy of chronic myelogenous leukemia].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):207-14. PubMed ID: 8434958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan].
    Armenta D; Espallargas C; Paz A; Rodríguez Martorel J; Ladines R; Alvarez C; Román J; Andrés P
    Sangre (Barc); 1996 Dec; 41(6):465-7. PubMed ID: 9148424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alfa as primary treatment of chronic myeloid leukemia: long-term follow-up of 71 patients observed in a single center.
    Kloke O; Opalka B; Niederle N
    Leukemia; 2000 Mar; 14(3):389-92. PubMed ID: 10720131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of an asymptomatic Ph-positive CML patient with 27 years of prolonged remission.
    Amikam D; Henig C; Sharon R; Tatarsky I; Ben-Ishai Z
    Am J Hematol; 1994 Aug; 46(4):358-62. PubMed ID: 8037191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
    Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
    Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.